the LifeAir G1
"This innovation is probably the best thing to happen to resuscitation care in our environment, and will significantly reduce infant and adult mortality rates from developing countries"
- Accident & Emergency Chair, Lagos Teaching Hospital, Nigeria
The New LifeAir Prototyes are here!
October 2021 | Ligand Innovation announced the release of two initial prototypes of the newest generation of the LifeAir ventilator.
“The key to this product innovation is not so technically complex, but rather that it simply meets the user’s basic and critical needs [and only those needs] where there was previously nothing.”
The LifeAir was specifically designed for use in developing countries to improve the quality of resuscitation care. It is well documented in literature that health workers have had to indefinitely use breathing bags to ventilate patients. The LifeAir automates this process, delivers controlled breaths in a more effective and efficient manner, releasing medical staff to attend to other patient needs, with tidal volume control, respiratory rate control, Inspiratory:Expiratory ratio settings with Pressure alarms.
This innovation has also been identified by the U.S Department of Defence, as a potential affordable alternative ventilator, in the treatment of lung paralysis from Botulinum neurotoxin, BoNT.
Conventional mechanical ventilators cost $15,000 - $30,000, a significantly expensive price point, especially for health facilities in developing countries. The LifeAir offers one of the most affordable options for efficient intermittent positive pressure ventilation today with additional control systems and pressure alarms.